Skip to content

AcrySof™ IQ Vivity™ DFT015 (REF DFT015.160)Recalls & reported problems

Alcon Laboratories, Inc. · Sterile UV and Blue Light Filtering Acrylic Foldable Aspheric Wavefront-Shaping Posterior Chamber Intraocular Lens · Class 3 · Implant

Adverse event reports
8
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00380652421157), received between Apr 26, 2021 and Mar 18, 2026 — classified as 5 injuries, 3 malfunctions.

The most frequently reported specific device problem is “Defective Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Defective Component1
  • Defective Device1
  • Device Dislodged or Dislocated1
  • Failure to Deliver1
  • Failure to Fold1
  • Malposition of Device1
  • Material Deformation1

Patient problems

  • Inflammation2
  • Visual Impairment2
  • Blurred Vision1
  • Endophthalmitis1
  • Eye Pain1
  • Headache1
  • Insufficient Information1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 18, 2026Material Opacification; Material Deformation

    A PHYSICIAN REPORTED THAT AFTER THE INTRAOCULAR LENS (IOL) IMPLANTATION SURGERY, THE LENS HAD GLISTENING AND OPACIFICATION AND THE PATIENT EXPERIENCED BLURRED VISION. HENCE THE PHYSICIAN HAS PLANNED TO EXPLANT THE LENS IN A SECONDARY PROCEDURE.

    Patient problems: Blurred Vision

    MAUDE report 24629600 ↗
  • MalfunctionFeb 21, 2026Failure to Fold; Failure to Deliver

    A HEALTHCARE PROFESSIONAL REPORTED THAT DURING INTRAOCULAR LENS (IOL) IMPLANTATION, IT WAS NOT POSSIBLE TO CORRECTLY IMPLANT THE LENS. THE ISSUE WAS RELATED TO THE IOL ITSELF, WHICH APPEARED EXTREMELY RIGID FROM THE BEGINNING AND BECAME STUCK INSIDE THE CARTRIDGE IMMEDIATELY. DUE TO THE RIGIDITY OF THE LENS, IT WAS NOT POSSIBLE TO EXTRACT IT OR REINSERT IT TO ATTEMPT A NEW IMPLANTATION. CONSEQUENTLY, A BACKUP LENS OF SAME MODEL BUT HALF A DIOPTER LESS POWER WAS USED TO COMPLETE THE SURGERY ON THE SAME DAY. ADDITIONAL INFORMATION HAS BEEN REQUESTED BUT IS NOT AVAILABLE AT THE TIME OF THIS REPORT.

    Patient problems: Insufficient Information

    MAUDE report 24408636 ↗
  • InjuryJan 3, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A HEALTH CARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, LENS WAS EXPLANTED IN SECONDARY PROCEDURE DUE TO REFRACTIVE ERROR, HEADACHE, TREMOR. PATIENTS SYMPTOMS RESOLVED AFTER LENS EXCHANGE. ADDITIONAL INFORMATION WAS REQUESTED. PRE-OP MEASUREMENTS: BCVA (INCLUDE DATE): 26-JUN-2024 -8.25 / -0.5 / 31 DEGREE /1.0 MRX (INCLUDE DATE): -6.50 /-0.25 / 2 / 1.0 ON 26-APR-2024 PREVIOUS CONTACT LENS USE WITHIN THE LAST YEAR: NO. POST-OP MEASUREMENTS: UCVA (INCLUDE DATE): 1.0 BCVA (INCLUDE DATE): 1.2 MRX (INCLUDE DATE): +0.75 / -0.50 / 61 DEGREE ON 22-NOV-2024.

    Patient problems: Headache; Shaking/Tremors; Visual Impairment

    MAUDE report 21068303 ↗
  • InjuryOct 31, 2023Malposition of Device; Malposition of Device

    A HEALTHCARE PROFESSIONAL REPORTED FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE INTRAOCULAR LENS HAD TO BE REMOVED DUE TO DISLOCATION WITHIN THE CAPSULE AND A SLIGHT RESIDUAL DEFECT. THE LENS WAS EXPLANTED AND REPLACED WITH COMPANY LENS IN A SECONDARY PROCEDURE. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Visual Impairment

    MAUDE report 18038806 ↗
  • InjuryAug 4, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PHYSICIAN REPORTED THAT FOLLOWING DAY OF AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED SEVERE INFLAMMATORY RESPONSE, EXUDATIVE MEMBRANE AROUND IOL, FUNDUS GLOW SEE HAZY. SECOND FOLLOW-UP ON (B)(6)-SITUATION WAS WORSEN, FUNDUS NOT SEEN, SEVERE EXUDATION AROUND IOL IN SPITE OF STEROIDS AND CYCLOPLEGICS. THE PATIENT HAD CONJUNCTIVAL INFLAMMATION, AQUEOUS CELL +2, AQUEOUS FIBRIN-PRESENT. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Inflammation

    MAUDE report 17458871 ↗
  • InjuryOct 19, 2022Defective Component; Device Dislodged or Dislocated; Defective Component; Device Dislodged or Dislocated

    A NON HEALTH CARE PROFESSIONAL REPORTED FOLLOWING IMPLANTATION OF INTRAOCULAR LENS (IOL), THE PATIENT EXPERIENCED CLOUDY VISION. THE LENS WAS EXPLANTED IN A SECONDARY PROCEDURE. ADDITIONAL INFORMATION HAS BEEN RECEIVED AND THERE WAS A QUALITY ISSUE WITH THE LENS THAT CAUSED OR CONTRIBUTED TO THE EVENT INDICATING LENS NOT CENTERED, POSSIBLE DAMAGE TO HAPTIC. THE LENS WAS EXCHANGED WITH ANOTHER LENS MODEL.

    Patient problems: Visual Disturbances

    MAUDE report 15632302 ↗
  • InjuryJul 15, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PHYSICIAN REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED EYE PAIN, INFLAMMATION AND ALSO SAID THAT IT LOOKS LIKE ENDOPHTHALMITIS AT THE HOSPITAL. THE DOCTOR HAD PRESCRIBED THE ANTIBIOTICS AS A TREATMENT AND PATIENT WAS UNDER OBSERVATION. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Endophthalmitis; Eye Pain; Inflammation

    MAUDE report 12173670 ↗
  • MalfunctionApr 26, 2021Defective Device; Defective Device

    A FACILITY REPRESENTATIVE REPORTED THAT DURING THE INSERTION OF AN INTRAOCULAR LENS (IOL) INTO AN EYE A SHAVING FROM THE EDGE OF THE OPTIC WAS NOTED. THE SURGEON CLIPPED IT OFF WITH MICRO SCISSORS. THE LENS REMAINS IMPLANTED WITH NO HARM TO THE PATIENT. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11726356 ↗

Other Extended depth of focus intraocular lens devices

All Extended depth of focus intraocular lens devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.